Neuroimaging as a method of «looking under the clinical threshold» of neurodegeneration
PDF (Русский)

Keywords

multiple sclerosis
Wilson–Konovalov’s disease
magnetic resonance imaging
neurodegeneration

How to Cite

Voloshina, N., Chernenko, M., Voloshin-Gaponov, I., Vasilovsky, V., Negreba, T., Kostyukovskaya, A., & Gaponov, P. (2021). Neuroimaging as a method of «looking under the clinical threshold» of neurodegeneration. Medicine Today and Tomorrow, 85(4), 61–68. https://doi.org/10.35339/msz.2019.85.04.09

Abstract

Adaptive properties of the nervous system and the phenomenon of neuroplasticity form the concept of a clinical threshold, due to which existing damage to the nervous system does not clinically manifest until a certain point. Clinical threshold is a complex of adaptive mechanisms based on the plastic properties of nervous tissue. High-field modern magnetic resonance tomographs provide an opportunity to look under the clinical threshold and timely prescribe or optimize therapy. Thanks to the timely conduct of magnetic resonance imaging of the brain, it is possible to identify preclinical changes in the nervous system, as well as timely identify adverse trends during the course of the disease in order to minimize damage to the nervous system. Changes in the ventricular system and subarachnoid spaces of the brain in patients with multiple sclerosis and Wilson–Konovalov’s disease were described. Changes were revealed that indicate the presence of atrophic changes characteristic of both demyelinating and neurodegenerative pathologies. Progressive atrophic changes in the brain with a stable clinical picture may serve as a sign of the loss of a neurological reserve. The phenomena of rapidly increasing atrophy of the brain, increasing atrophy of the corpus callosum and cerebellum in the early stages of the pathological process are unfavorable prognostic signs of both multiple sclerosis and Wilson–Konovalov’s disease. Timely assessment of the severity of atrophy can help in deciding on a drug change, a complex of intensive neuroprotective measures, and to personify therapy.

https://doi.org/10.35339/msz.2019.85.04.09
PDF (Русский)

References

Giffroy X., Maes N., Albert A., Maquet P., Crielaard J.M., Dive D. (2017). Do evoked potentials contribute to the functional follow-up and clinical prognosis of multiple sclerosis? Acta Neurol. Belg., vol. 117 (1), pp. 53–59, DOI https://doi.org/10.1007/s13760-016-0650-1.

Kobys T.A. (2016). Neirovizualizatsionnyie prediktory prohressirovaniia invalidizatsii pri rasseiannom skleroze [Neuroimaging predictors of the progression of disability in multiple sclerosis]. Vestnik sovremennoi klinicheskoi meditsiny – Bulletin of Modern Clinical Medicine, vol. 9, issue 4, pp. 7–14, DOI https://doi.org/10.20969/VSKM.2016.9(4).7-14 [in Russian].

Giffroy Х., Maes N., Albert А., Maquet Р., Crielaard J.-M. (2016). Multimodal evoked potentials for functional quantification and prognosis in multiple sclerosis. BMC Neurol., vol. 16, p. 83, DOI https://doi.org/10.1186/s12883-016-0608-1.

Honcharova Z.A., Luneva S.S., Senin S.I. (2015). PsevdoVilson–Konovalov – vozvrashcheniie k primatu klinicheskoho diahnoza v XXI veke [PseudoWilson–Konovalov is a return to the primacy of clinical diagnosis in the twenty-first century]. Arkhiv vnutrennei meditsiny – The Russian Archives of Internal Medicine, № 3 (23), pp. 48–53, DOI 10.20514/2226-6704-2015-0-3-48-53 [in Russian].

Podzolkov V.I., Pokrovskaia A.Ye. (2017). Trudnosti diahnostiki i lecheniia bolezni Vilsona–Konovalova [Difficulties in the diagnosis and treatment of Wilson–Konovalov disease]. Klinicheskaia meditsina – Clinical Medicine, vol. 9, № 5, pp. 465–470, DOI 10.20514/2226-6704-2015-0-3-48-5310.18821/0023-2149-2017-95-5-465-470 [in Russian].

Chernenko M.Ye., Vovk V.І. (2018). Neiroplastychnist u khvorykh na rozsiianyi skleroz v umovakh zapalnoho protsesu [Neuroplasticity in patients with multiple sclerosis in the inflammatory process]. Ukrainskyi visnyk psykhonevrolohii – Ukrainian Bulletin of Psychoneurology, vol. 26, issue 2 (95), pp. 29–32, DOI 10.36927/2079-0325 [in Ukrainian].

Voloshin-Haponov I.K. (2013). Strukturnyie izmeneniia holovnoho mozha u bolnykh s hepatotserebralnoi deheneratsiiei [Structural changes in the brain in patients with hepatocerebral degeneration]. Mezhdunarodnyi nevrolohicheskii zhurnal – International Neurological Journal, issue 2 (56), pp. 9–12 [in Russian].

Gupta A., Chakravarthi S., Goyal M.K. (2013). «Face of giant panda»: a rare imaging sign in Wilson’s disease. Journal of the Association of Physicians, vol. 107, issue 7, pp. 579, DOI 10.1093/qjmed/hct217.

Sinha S., Taly A., Ravishankar S., Prashanth L.K., Vasudev M.K. (2010). Wilson’s disease: 31P and 1H MR spectroscope and clinical correlation. Diagnostic Neuroradiology, vol. 52, pp. 977–985, DOI 10.1007/s00234-010-0661-1.

Voloshina N.P., Vasilovskii V.V., Chernenko M.Ye. (2013). Vliianiie infektsionnoho faktora na sostoianiie hematoentsefalicheskoho bariera u bolnykh rasseiannym sklerozom [The influence of an infectious factor on the state of the blood-brain barrier in patients with multiple sclerosis]. Ukrainskyi visnyk psykhonevrolohii – Ukrainian Bulletin of Psychoneurology, № 21 (1), pp. 5–7, DOI https://doi.org/10.36927/2079-0325 [in Russian].

Walter U. (2010). Transcranial sonography in brain disorders with trace metal accumulation. Int. Rev. Neurobiol., vol. 90, pp. 166–178, DOI https://doi.org/10.1016/S0074-7742(10)90012-3.